Model’s prediction improvement statistically significant compared to models trained with clinical features alone. »
12/30/24

50% success in initiating luminal breast cancer organoids from tumor scrapes. »
12/31/24

Adding bevacizumab to FTD/TPI resulted in more prolonged progression-free survival. »
01/02/25

tumour cells and microenvironment increasingly engage in communication through WNT signalling. »
01/02/25

Patients with UICC grade IV tumours and percutaneous endoscopic gastrostomy tube had significantly shorter OS. »
01/02/25

Independent prognostic factors for PFS and OS included performance status and first-line regimen. »
01/03/25

Multiplex imaging of AI glands demonstrated an increase ELF5 + /WNT5a + luminal cells. »
01/03/25

No severe adverse events, and toxicities tolerable. »
01/04/25

Patients with perioperative infection displayed significantly impaired OS. »
01/07/25

L19-IL2 treatment induced significant influx of immune cells into tumor microenvironment. »
01/07/25